title: Subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with antibodies to voltage-gated calcium channels: differential effect of immunosuppressive therapy on central and peripheral defects.
authors.forename: J M
authors.initials: JM
authors.lastname: Goldstein
authors.forename: S G
authors.initials: SG
authors.lastname: Waxman
authors.forename: T L
authors.initials: TL
authors.lastname: Vollmer
authors.forename: B
authors.initials: B
authors.lastname: Lang
authors.forename: I
authors.initials: I
authors.lastname: Johnston
authors.forename: J
authors.initials: J
authors.lastname: Newsom-Davis
mesh_terms: D001323:Autoantibodies / Q000097:blood*; D015220:Calcium Channels / Q000276:immunology*; D002526:Cerebellar Diseases / Q000276:immunology* / Q000628:therapy; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy; D015640:Ion Channel Gating / Q000276:immunology; D015624:Lambert-Eaton Myasthenic Syndrome / Q000276:immunology* / Q000628:therapy; D008875:Middle Aged
chemical_list: D001323:Autoantibodies; D015220:Calcium Channels